2nd Quarter - Report
ABIOMED, INC for ABIOMED, INC
Firm
Client
Income
—
Expenses
$180,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
- Issues relating to FDA user fee reauthorization and the use of real world data - Support heart recovery as the standard of care and increased diversity CV clinical trials - Issues relating to the supply chain for medical products - Education on FDA breakthrough medical device issues and use of RWE
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE MITCHELL | Office of Representative Gwen Graham (D-FL), Intern, 8/2016-12/2016 Horizon Therapetuics, Fellow, 6/2017-10/2017 California Life Science Association CLSA), Manager GA, 10/2017-4/2021 |
| MELISSA DODSON SCHOOLEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.